Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 27 04:00PM ET
13.65
Dollar change
-0.17
Percentage change
-1.23
%
IndexRUT P/E- EPS (ttm)-0.75 Insider Own45.92% Shs Outstand31.39M Perf Week0.22%
Market Cap455.09M Forward P/E- EPS next Y-2.45 Insider Trans-0.14% Shs Float18.03M Perf Month-7.96%
Income-21.77M PEG- EPS next Q-0.17 Inst Own48.24% Short Float10.06% Perf Quarter18.80%
Sales87.17M P/S5.22 EPS this Y97.09% Inst Trans-0.83% Short Ratio22.56 Perf Half Y-14.31%
Book/sh7.40 P/B1.85 EPS next Y-2692.34% ROA-5.73% Short Interest1.81M Perf Year23.19%
Cash/sh10.61 P/C1.29 EPS next 5Y- ROE-9.07% 52W Range9.47 - 18.44 Perf YTD-9.54%
Dividend Est.- P/FCF4.09 EPS past 5Y- ROI-7.04% 52W High-25.98% Beta-0.50
Dividend TTM- Quick Ratio2.32 Sales past 5Y0.00% Gross Margin97.06% 52W Low44.14% ATR (14)0.98
Dividend Ex-Date- Current Ratio2.32 EPS Y/Y TTM74.97% Oper. Margin-38.60% RSI (14)43.86 Volatility6.50% 6.35%
Employees130 Debt/Eq0.28 Sales Y/Y TTM- Profit Margin-24.98% Recom1.00 Target Price21.00
Option/ShortNo / Yes LT Debt/Eq0.25 EPS Q/Q226.95% Payout- Rel Volume1.37 Prev Close13.82
Sales Surprise355.69% EPS Surprise238.78% Sales Q/Q- EarningsNov 07 BMO Avg Volume80.40K Price13.65
SMA20-4.93% SMA50-8.52% SMA200-8.31% Trades Volume114,666 Change-1.23%
Date Action Analyst Rating Change Price Target Change
Jan-05-24Initiated Oppenheimer Outperform $22
Apr-03-23Initiated H.C. Wainwright Buy $25
Feb-07-24 07:00AM
Jan-29-24 08:14AM
Jan-03-24 07:00AM
Dec-28-23 07:01AM
Nov-23-23 11:47AM
07:00AM Loading…
Nov-22-23 07:00AM
Nov-07-23 08:25AM
08:06AM
07:00AM
Oct-12-23 07:00AM
Sep-21-23 07:00AM
Sep-16-23 01:01AM
Sep-07-23 07:00AM
Aug-29-23 07:00AM
Aug-10-23 07:00AM
08:40AM Loading…
Aug-08-23 08:40AM
07:00AM
Aug-04-23 06:36AM
Aug-01-23 07:00AM
Jul-21-23 06:43AM
Jun-06-23 07:00AM
May-15-23 06:03AM
May-13-23 08:03AM
May-10-23 07:00AM
Apr-30-23 10:26AM
Apr-04-23 07:00AM
Mar-29-23 07:00AM
Mar-08-23 06:02AM
Mar-06-23 07:00AM
Feb-27-23 07:00AM
07:00AM Loading…
Feb-09-23 07:00AM
Jan-09-23 07:00AM
Dec-22-22 08:07AM
Dec-20-22 10:03AM
Dec-19-22 04:30PM
Dec-14-22 10:24AM
Dec-09-22 01:41PM
Dec-08-22 04:12PM
10:58AM
08:24AM
07:00AM
Nov-22-22 07:00AM
Nov-07-22 07:00AM
Aug-30-22 07:00AM
Aug-11-22 07:00AM
Aug-04-22 07:00AM
Jul-19-22 07:00AM
Jul-14-22 10:47AM
Jul-06-22 07:00AM
Jun-01-22 07:00AM
May-12-22 07:00AM
May-11-22 09:30AM
May-10-22 07:00AM
Mar-15-22 07:00AM
Feb-23-22 08:00AM
Feb-04-22 01:27PM
Feb-03-22 09:38AM
Jan-05-22 08:00AM
Dec-17-21 08:00AM
Dec-09-21 07:00AM
Nov-18-21 08:00AM
Nov-05-21 08:32AM
Nov-02-21 04:26PM
Oct-28-21 10:21PM
Entrada Therapeutics, Inc. operates as a biotechnology company. It focuses on delivery of biomolecules into the cell to treat devastating diseases. The firm offers intracellular enzyme replacement therapy and protein-protein interaction inhibitors programs. The company focuses on creating and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to target and engage underlying drivers of diseases. Entrada Therapeutics was founded by Dehua Pei in September 22, 2016 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Doshi DipalCEOFeb 15Sale15.001,00015,000243,279Feb 20 04:37 PM
Doshi DipalCEOJan 16Sale15.991,00015,990244,279Jan 18 04:32 PM
WENTWORTH KORY JAMESChief Financial OfficerDec 26Option Exercise2.109419749,665Dec 26 04:35 PM
WENTWORTH KORY JAMESChief Financial OfficerDec 26Sale16.67941,56749,571Dec 26 04:35 PM
WENTWORTH KORY JAMESChief Financial OfficerDec 22Option Exercise2.1010,20621,43359,777Dec 26 04:35 PM
WENTWORTH KORY JAMESChief Financial OfficerDec 22Sale15.6910,206160,12449,571Dec 26 04:35 PM
WENTWORTH KORY JAMESChief Financial OfficerDec 21Option Exercise2.102,2004,62051,771Dec 26 04:35 PM
WENTWORTH KORY JAMESChief Financial OfficerDec 21Sale15.072,20033,15549,571Dec 26 04:35 PM
Doshi DipalPresident and CEODec 20Sale15.001,00015,000245,279Dec 22 04:38 PM
Doshi DipalPresident and CEONov 13Sale16.231,00016,230246,279Nov 13 04:35 PM
Doshi DipalPresident and CEOOct 17Sale15.001,00015,000247,279Oct 19 05:27 PM
Doshi DipalPresident and CEOSep 13Sale15.001,00015,000248,279Sep 15 04:21 PM
Dowden Nathan JChief Operating OfficerSep 06Sale13.4797213,08948,168Sep 06 05:07 PM
WENTWORTH KORY JAMESChief Financial OfficerSep 06Sale13.4895012,80649,571Sep 06 05:11 PM
KREHER NERISSAChief Medical OfficerSep 06Sale13.4889212,02240,037Sep 06 05:08 PM
Doshi DipalPresident and CEOAug 14Sale15.671,00015,671201,069Aug 16 04:32 PM
KREHER NERISSAChief Medical OfficerAug 04Option Exercise2.106,89814,48634,028Aug 04 04:50 PM
KREHER NERISSAChief Medical OfficerAug 04Sale14.146,89897,52127,130Aug 04 04:50 PM
KREHER NERISSAChief Medical OfficerAug 03Option Exercise2.109,46419,87436,594Aug 04 04:50 PM
KREHER NERISSAChief Medical OfficerAug 03Sale14.749,464139,53027,130Aug 04 04:50 PM
KREHER NERISSAChief Medical OfficerAug 02Option Exercise2.1010,34821,73137,478Aug 04 04:50 PM
KREHER NERISSAChief Medical OfficerAug 02Sale15.1910,348157,16827,130Aug 04 04:50 PM
WENTWORTH KORY JAMESChief Financial OfficerJul 11Option Exercise2.103,8848,15640,631Jul 12 04:34 PM
Sethuraman NatarajanChief Scientific OfficerJul 11Sale18.0414,852267,915153,447Jul 12 04:32 PM
Dowden Nathan JChief Operating OfficerJul 11Sale18.053,89770,33335,376Jul 12 04:33 PM
WENTWORTH KORY JAMESChief Financial OfficerJul 11Sale18.003,88469,90436,747Jul 12 04:34 PM
WENTWORTH KORY JAMESChief Financial OfficerJul 10Option Exercise2.106,11612,84442,863Jul 12 04:34 PM
WENTWORTH KORY JAMESChief Financial OfficerJul 10Sale17.986,116109,95836,747Jul 12 04:34 PM
Dowden Nathan JChief Operating OfficerJul 10Sale18.003,20057,60539,273Jul 12 04:33 PM
Sethuraman NatarajanChief Scientific OfficerJul 10Sale18.003,02654,474168,299Jul 12 04:32 PM
WENTWORTH KORY JAMESChief Financial OfficerJun 29Option Exercise2.108,79018,45936,747Jun 30 04:32 PM
Dowden Nathan JChief Operating OfficerJun 22Sale16.027,097113,70042,473Jun 22 04:46 PM
WENTWORTH KORY JAMESChief Financial OfficerJun 21Option Exercise2.1017,50036,75045,457Jun 23 04:20 PM
WENTWORTH KORY JAMESChief Financial OfficerJun 21Sale15.0117,500262,64827,957Jun 23 04:20 PM
Dowden Nathan JChief Operating OfficerJun 20Sale14.948,885132,70449,570Jun 22 04:46 PM
Doshi DipalPresident and CEOApr 27Sale13.712,00027,422202,069May 01 04:38 PM
Sethuraman NatarajanChief Scientific OfficerApr 17Sale18.003,96171,316171,325Apr 19 06:06 PM
Doshi DipalPresident and CEOApr 17Sale18.012,09237,675204,069Apr 19 06:07 PM
Doshi DipalPresident and CEOMar 27Sale14.722,00029,435255,811Mar 29 05:12 PM
WENTWORTH KORY JAMESChief Financial OfficerMar 02Sale10.531,74718,38942,157Mar 03 04:37 PM
KREHER NERISSAChief Medical OfficerMar 02Sale10.561,64117,33641,330Mar 03 04:32 PM